Metabolic Profiling of Escherichia coli-Based Cell-Free Expression Systems for Process Optimization
Citations Over TimeTop 13% of 2019 papers
Abstract
Biotechnology has transformed the production of various chemicals and pharmaceuticals due to its efficient and selective processes, but it is inherently limited by its use of live cells as "biocatalysts." Cell-free expression (CFE) systems, which use a protein lysate isolated from whole cells, have the potential to overcome these challenges and broaden the scope of biomanufacturing. Implementation of CFE systems at scale will require determining clear markers of lysate activity and developing supplementation approaches that compensate for potential variability across batches and experimental protocols. Towards this goal, we use metabolomics to relate lysate preparation and performance to metabolic activity. We show that lysate processing affects the metabolite makeup of lysates, and that lysate metabolite levels change over the course of a CFE reaction regardless of whether a target compound is produced. Finally, we use this information to develop ways to standardize lysate activity and to design an improved CFE system.
Related Papers
- → Recombinant Protein Expression in Escherichia coli (E.coli): What We Need to Know(2018)115 cited
- [A study on beta-lactamase activity of biofilm Escherichia coli].(2001)
- Bacteriostatic Experiment of Twelve Species of Chinese Medicines and Its Compounds Against Escherichia Coli(2004)
- Damaging effect of pressurized CO_2 on cell membrane of Escherichia coli(2013)
- A study on β-lactamase activity of biofilm Escherichia coli(2001)